Zobrazeno 1 - 10
of 251
pro vyhledávání: '"Gosselin NH"'
Autor:
Hruska MW; Kyowa Kirin Inc., Princeton, New Jersey, USA., Sid-Otmane L; Certara Drug Development Solutions, Princeton, New Jersey, USA., Gosselin NH; Certara Drug Development Solutions, Princeton, New Jersey, USA., Quattrocchi E; Kyowa Kirin Pharmaceutical Development Ltd, Marlow, UK., Lee SK; Morphic Therapeutic, Waltham, Massachusetts, USA., Mascelli MA; Chinook Therapeutics Inc, Seattle, Washington, USA., Mehta K; Kyowa Kirin Inc., Princeton, New Jersey, USA., Jan de Beur SM; Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA., Marsteller D; Kyowa Kirin Inc., Princeton, New Jersey, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.
Autor:
Song IH; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., 500 East Kendall Street, Cambridge, MA, 02142, USA. ivy.song@takeda.com., Chen G; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., 500 East Kendall Street, Cambridge, MA, 02142, USA., Hayes S; ICON plc, Reading, UK., Farrell C; ICON plc, Reading, UK., Jomphe C; Certara Drug Development Solutions, Princeton, NJ, USA., Gosselin NH; Certara Drug Development Solutions, Princeton, NJ, USA., Sun K; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., 500 East Kendall Street, Cambridge, MA, 02142, USA.
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.
Autor:
Mehta K; Kyowa Kirin Inc., Princeton, New Jersey, USA., Gosselin NH; Certara Strategic Consulting, Princeton, New Jersey, USA., Insogna K; Yale University School of Medicine, New Haven, Connecticut, USA., Barriere O; Certara Strategic Consulting, Princeton, New Jersey, USA., Quattrocchi E; Kyowa Kirin Pharmaceutical Development Ltd, Marlow, UK., Hruska MW; Kyowa Kirin Inc., Princeton, New Jersey, USA., Marsteller D; Kyowa Kirin Inc., Princeton, New Jersey, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Nov; Vol. 116 (5), pp. 1343-1351. Date of Electronic Publication: 2024 Aug 12.
Autor:
Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, London, UK. Electronic address: k.ray@imperial.ac.uk., Gunn LH; Department of Public Health Sciences and School of Data Science, University of North Carolina at Charlotte, Charlotte, NC, USA; Department of Primary Care and Public Health, Imperial College, London, UK., Conde LG; Novartis Pharma AG, Basel, Switzerland., Raal FJ; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Wright RS; Division of Preventive Cardiology and the Department of Cardiology, Mayo Clinic, Rochester, MN, USA., Gosselin NH; Certara, Princeton, NJ, USA., Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Canada., Koenig W; Deutsches Herzzentrum München, Technische Universität München, and German Center for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and the Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany., Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA., Landmesser U; Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum Charité, Charité-Universitätsmedizin Berlin, Friede Springer Cardiovascular Prevention Center@Charité, DZHK, Partner Site Berlin, Germany.
Publikováno v:
Atherosclerosis [Atherosclerosis] 2024 Apr; Vol. 391, pp. 117472. Date of Electronic Publication: 2024 Feb 15.
Autor:
Gosselin NH; Certara, Cambridge, Massachusetts, USA., Schuck VJA; Certara, Cambridge, Massachusetts, USA., Barriere O; Certara, Cambridge, Massachusetts, USA., Kulmatycki K; Novartis Institute for Biomedical Research, Cambridge, Massachusetts, USA., Margolskee A; Novartis Institute for Biomedical Research, Cambridge, Massachusetts, USA., Smith P; Certara, Cambridge, Massachusetts, USA., He Y; Novartis Institute for Biomedical Research, Cambridge, Massachusetts, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Feb; Vol. 113 (2), pp. 328-338. Date of Electronic Publication: 2022 Nov 14.
Autor:
Lee SK; Ultragenyx Pharmaceutical Inc., Novato, California, USA., Gosselin NH; Certara Strategic Consulting, Princeton, New Jersey, USA., Jomphe C; Certara Strategic Consulting, Princeton, New Jersey, USA., McKeever K; Ultragenyx Pharmaceutical Inc., Novato, California, USA., Putnam W; Ultragenyx Pharmaceutical Inc., Novato, California, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Nov; Vol. 11 (11), pp. 1264-1272. Date of Electronic Publication: 2022 Jul 31.
Autor:
Hsia DS; Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States., Gosselin NH; Certara USA, Inc, Princeton, New Jersey., Williams J; Cincinnati Children's Hospital/University of Cincinnati, Cincinnati, Ohio, United States., Farhat N; Certara USA, Inc, Princeton, New Jersey., Marier JF; Certara USA, Inc, Princeton, New Jersey., Shih W; Vivus, Inc, Campbell, California., Peterson C; Vivus, Inc, Campbell, California., Siegel R; Cincinnati Children's Hospital/University of Cincinnati, Cincinnati, Ohio, United States.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2020 Apr; Vol. 22 (4), pp. 480-491. Date of Electronic Publication: 2019 Dec 18.
Autor:
Lee SK; Ultragenyx Pharmaceutical Inc., Novato, California, USA., Gosselin NH; Certara Strategic Consulting, Princeton, New Jersey, USA., Taylor J; Ultragenyx Pharmaceutical Inc., Novato, California, USA., Roberts MS; Ultragenyx Pharmaceutical Inc., Novato, California, USA., McKeever K; Ultragenyx Pharmaceutical Inc., Novato, California, USA., Shi J; Ultragenyx Pharmaceutical Inc., Novato, California, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2022 Jan; Vol. 62 (1), pp. 87-98. Date of Electronic Publication: 2021 Aug 27.
Autor:
Côté, Jonathan1 (AUTHOR), Bouchard, Michèle1 (AUTHOR) michele.bouchard@umontreal.ca
Publikováno v:
PLoS ONE. 10/23/2024, Vol. 19 Issue 10, p1-24. 24p.
Autor:
Kaushal, Neeraj1 (AUTHOR), Attarwala, Husain1 (AUTHOR), Iqbal, Mir Javid1 (AUTHOR), Saini, Rajnish1 (AUTHOR), Van, Linh1 (AUTHOR) linh.van@modernatx.com, Liang, Min1 (AUTHOR)
Publikováno v:
CTS: Clinical & Translational Science. Aug2024, Vol. 17 Issue 8, p1-13. 13p.